Madrigal Pharmaceuticals (MDGL) revenue

Revenue · fiscal 2025
$958.40M

Madrigal Pharmaceuticals (MDGL) reported revenue of $958.40M in fiscal 2025 (the year ended December 31, 2025). That is 432.1% higher than the $180.13M of fiscal 2024. Figures as of 18 Nov 2026, 07:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$958.40M
Change on fiscal 2024
+432.1%
Highest on record
$958.40Mfiscal 2025
Lowest on record
$147.00Kfiscal 2012
Fiscal years on record
32012–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Madrigal Pharmaceuticals revenue, in more detail

Across the 3 fiscal years on record (2012–2025), the highest was $958.40M in fiscal 2025 and the lowest $147.00K in fiscal 2012.

History · 3 fiscal years

Revenue by fiscal year

Madrigal Pharmaceuticals revenue, year by year

Madrigal Pharmaceuticals (MDGL) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$958.40M 432.1% up
2024$180.13M—
2012$147.00K—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Madrigal Pharmaceuticals and comparable companies
CompanyRevenueFiscal year
Qiagen QGEN$2.09B2025
Insulet PODD$2.71B2025
Bruker BRKR$3.44B2025
Globus Medical GMED$2.94B2025
Madrigal Pharmaceuticals MDGL$958.40M2025
Henry Schein HSIC$13.18B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on MDGL

Madrigal Pharmaceuticals, figure by figure

Madrigal Pharmaceuticals (MDGL) overview: price, valuation and scorecardAll health care companies by market value

Madrigal Pharmaceuticals revenue: questions and answers

What is Madrigal Pharmaceuticals's revenue?

Madrigal Pharmaceuticals (MDGL) reported revenue of $958.40M in fiscal 2025 (the year ended December 31, 2025). That is 432.1% higher than the $180.13M of fiscal 2024.

What are the highest and lowest revenue figures on record for Madrigal Pharmaceuticals?

Across the 3 fiscal years on record (2012–2025), the highest was $958.40M in fiscal 2025 and the lowest $147.00K in fiscal 2012.

How is Madrigal Pharmaceuticals's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Madrigal Pharmaceuticals (MDGL) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/MDGL/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.